A multicenter, randomized, open-label pilot trial assessing the efficacy and safety of etanercept 50 mg twice weekly followed by etanercept 25 mg twice weekly, the combination of etanercept 25 mg twice weekly and acitretin, and acitretin alone in patients with moderate to severe psoriasis

Peer Review reports

Original Submission
28 Oct 2015	Submitted	Original manuscript
7 Feb 2016	Reviewed	Reviewer Report - Ravi Hiremagalore
17 Feb 2016	Reviewed	Reviewer Report - Jennifer Cather
24 Feb 2016	Reviewed	Reviewer Report - Siegfried Segaert
17 May 2016	Author responded	Author comments - Joo-Heung Lee
Resubmission - Version 2
17 May 2016	Submitted	Manuscript version 2
26 May 2016	Reviewed	Reviewer Report - Ravi Hiremagalore
6 Jul 2016	Author responded	Author comments - Joo-Heung Lee
Resubmission - Version 3
6 Jul 2016	Submitted	Manuscript version 3
Publishing
8 Jul 2016	Editorially accepted
25 Jul 2016	Article published	10.1186/s12895-016-0048-z

Back to article page